Population over 80 years who require surgery for degenerative aortic stenosis has largely increased in the past decades. We have compared short-and mid-term results for conventional aortic valve replacement (AVR) for calcific-degenerative aortic stenosis in older and younger than 80 years operated at our institution between April 2004 and December 2008. Predictors of mortality and major adverse cardio and cerebrovascular events (MACCEs) on the postoperative and follow-up period were determined through multivariable analysis. Four hundred and fifty-one patients were included in the study. Ninety-four (20.8%) were G80. Previous cardiac surgery wodds ratio (OR)s4.08, Ps0.047x, renal failure (ORs6.75, P-0.001), concomitant coronary artery bypass grafting (CABG) (ORs2.57, Ps0.034), female sex (ORs2.49, Ps0.047), and severe pulmonary hypertension (ORs3.68, Ps0.024) were independent predictors of in-hospital mortality. In the followup, age G80 years wHazard ratio (HR)s2.44, Ps0.02x, high blood pressure (HBP) (HRs5.2, Ps0.025) and peripheral arterial disease (PAD) (HRs5.1, P-0.001) were independent predictors for late mortality. Only PAD (HRs3.55, Ps0.014) and HBP (HRs8.24, Ps0.04) were independent predictors for late cardiac mortality. Renal failure (ORs2.57, Ps0.005), severe pulmonary hypertension (ORs3.49, Ps0.005) and concomitant CABG (ORs2.49, Ps0.002) were independent predictors for postoperative MACCEs. Diabetes mellitus (HRs2.03, Ps0.033) and PAD (HRs2.3, Ps0.041) were independent predictors for MACCEs in the follow-up. According to these data, we can conclude that conventional open AVR for degenerative aortic stenosis grants good early-and mid-term outcomes in octogenarians in our experience.
Introduction
The life expectancy increase has led to a spectacular rise of geriatric population in developed countries. The most common structural cardiac pathology within this population stratum is the degenerative-calcific aortic valve disease w1, 2x. Traditionally age and comorbidities associated with it are the reasons for which postoperative results for aortic valve replacement (AVR) in elderly patients were worse w3, 4x. In recent years, however, the scientific literature reporting lower morbimortality after AVR in elderly patients w5-7x has continued to increase. The aim of this study was to compare the short-and mid-term results of conventional AVR due to degenerative aortic stenosis in patients above and below 80 years of age and determine the risk factors for major adverse cardio and cerebrovascular events (MACCEs) after this surgery.
Material and methods

Patients
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first AVR (no other concomitant valve procedure associated) between April 2004 and October 2008 at our institution were included in this study. Patients under 60 years were excluded as degenerative calcification of the aortic valve is an infrequent cause of aortic stenosis in younger patients. Patients undergoing concomitant coronary surgery were also included because of the shared common risk factors w8x. Two groups were compared according to their age at the time of the intervention: under 80 years old, 80 years old and over 80 years old.
Surgical technique
AVR was performed with conventional cardiopulmonary bypass (CPB) and ascending aorta cross-clamping. We searched for ascending aorta and aortic arch calcification with epiaortic ultrasonography prior to selecting the site of cannulation. The selected size and brand of the prosthesis depended on the surgeons criteria. The prosthesis type (mechanical or biological) was chosen based on the patient's preferences, life expectancy and comorbidities together with the doctor's criteria.
Demographic, preoperative and surgical information
Retrospective information regarding the patient's clinical profile prior to the operation was collected. An assessment of the surgical risk based on the EuroSCORE scale w9x was done. Surgical data were also collected: type and size of prosthesis, duration of the surgery, CPB run time, associated coronary artery bypass grafting (CABG).
Events
We defined the postoperative period as the following: 30 days after the intervention or the postoperative inhospital stay. During this period of time, we evaluated: 1. Mortality. 2. Grouped MACCEs: including a) mortality; b) acute cerebrovascular accidents (ACVAs); c) postoperative acute myocardial infarction (AMI); d) postoperative renal failure with the need of haemofiltration or haemodialysis; e) definitive pacemaker implantation; and f) mediastinitis.
Patients were contacted by telephone call and underwent routine check-ups at our centre on a periodic but not uniform basis. During the follow-up, the following events were registered: 1. Mortality for all causes. 2. Cardiac mortality. 3. Grouped MACCEs, including: a) cardiac mortality; b) ACVAs; c) readmission to hospital due to cardiac cause; d) AMI; e) prosthetic replacement; f) thromboembolic complications; g) prosthetic endocarditis; and h) bleeding complications.
Patients who received a mechanical prosthesis received long-term anticoagulation with acenocumarol. Patients who received a bioprosthesis received long-term antiagregation, except those who needed to be anticoagulated for some other reason (atrial fibrillation, previous embolism, ...).
Statistical analysis
The distribution of preoperative and surgical variables in both group ages was compared. Comparisons of categorical variables were done with the x -test or Fisher's exact-2 test. The continuous variables inter-group differences were analysed either with unpaired t-test or with the Mann-Whitney U-test. Statistically significant differences were considered when P-0.05. Statistics presented were calculated only from valid data, ignoring missing data.
The predicting variables for the studied events were determined through binary logistic regression. Results for the multivariate testing were expressed in odds ratio (OR), their confidence interval (CI) and P-value. Medium term event-free survival was assessed using Kaplan-Meier estimation with its corresponding 95% CI. A Mantel-Haenszel 'log-rank' test was applied to analyse survival differences. By applying Cox's proportional hazard model, the predictive factors for outcomes during the follow-up period were also analysed.
Statistical analysis was performed using SPSS V. 15.0. For ᮋ Windows . 
Results
Sample description
Four hundred and fifty-one patients were included. Ninety-four (20.8%) were G80 years old. The preoperative characteristics are summarized in Table 1 . The predictive risk variables were rather homogeneous in both groups. A higher prevalence of renal failure (Ps0.014) and previous myocardial infarction (Ps0.013) in the octogenarian group was observed. According to the EuroSCORE scale, the surgical risk was higher in the eldest group w12.14% vs. 6.7% (P-0.001)x. Table 1 summarizes the most relevant operating details. The proportion of patients with bioprosthesis was significantly higher in the eldest group (95.7% vs. 64.7%, P-0.001). There were no significant differences in the prosthetic size between both groups.
Postoperative results
The postoperative results are summarized in Table 2 . No significant differences were observed in MACCEs incidences (Ps0.719) or in hospital mortality (Ps0.805). The adjusted death rate was one for the under 80 years and 0.61 for the octogenarians. Table 3 shows the multivariate analysis results for hospital mortality and postoperative MACCEs. Previous cardiac surgery (ORs4.08, 95% CI 1.37-12.6), renal failure (ORs6.75, 95% CI 2.76-16.55), concomitant CABG (ORs2.57, 95% CI 1.07-6.16), female sex (ORs2.49, 95% CI 1.01-6.1) and severe pulmonary hypertension (ORs3.68, 95% CI 1.19-11.4) turned out to be independent predictors of hospital mortality. Renal failure (ORs2.57, 95% CI 1.33-4.99) concomitant CABG (ORs2.49, 95% CI 1.41-4.4) and severe pulmonary hypertension (ORs3.49, 95% CI 1.46-8.36) were independent predictors for postoperative MACCEs. The age G80 years did not significantly increase the in-hospital mortality (ORs0.85, 95% CI 0.3-2.42) nor the incidence of grouped MACCESs (ORs0.9, 95% CI 0.46-1.96).
Follow-up
Mean follow-up was 30.1 months wstandard deviation (S.D.) 14.1x for the group below 80 years and 27.1 (S.D. 14) for the octogenarians. Eleven patients (3.3%) were lost in the younger group and 4 (4.6%) in the older. Table 4 shows each groups mean survival for each one of the studied events. Differences were noticed in unadjusted survival (Ps0.002) and MACCEs free survival (0.038). MACCEs free survival differences might be explained because a greater incidence of hospital readmissions in the octogenarian group (20.5% vs. 11.2%, Ps0.03). There were no significant differences in cardiac mortality (Ps0.055). Figs. 1, 2 and 3 represent the survival curves per age group for each one of the events during the follow-up.
In Table 5 , we show the results obtained for each one of the events during the follow-up after applying Cox's proportional hazard model. High blood pressure (HBP) wHazard ratio (HR)s5.23; Ps0.025x, peripheral arterial disease (PAD) (HRs5.06; P-0.001) and age over 80 years (HRs2.44; Ps0.001) were independent mortality predictors. HBP (HRs8.24; Ps0.040) and PAD (HRs3.55; Ps0.014) were independent predictors of cardiac mortality. PAD (HRs2.3; Ps0.041) and diabetes mellitus (HRs2.03; Ps0.033) were independent predictors of MACCEs during the follow-up. The only significant risk increase from being an octogenarian is that of the incidence of all-cause mortality. Neither a higher cardiac mortality (Ps0.080; HRs2.26; 95% CI 0.91-5.63) nor a greater incidence of grouped MACCEs (Ps0.113; HRs1.77; 95% CI 0.87-3.57) were associated to the age of G80 years.
Discussion
Degenerative aortic stenosis is the most common structural cardiopathy in octogenarians and the predominant type of surgery in this group of age AVR w1, 2x. AVR is recommended due to the sombre prognosis for symptomatic severe aortic stenosis. The development of less aggressive techniques than open surgery (implantation via transcatheter) has restored the medical population's interest in valvular replacement and forces us to review the real current state of conventional surgery in elderly patients.
Technical innovations together with the evolution of prosthesis designs in the last quarter century have allowed the reduction of complications inherent to conventional AVR in elderly patients. According to the North American Society of Thoracic Surgeons national database w5x, mortality between 1996 and 2007 decreased by 24% and the incidence of cerebrovascular accidents decreased by 27%, whereas the patient population risk profile significantly worsened (particularly, population over 70 years of age increased by 10%).
Mortality published in current literature oscillates between 5% and 10% w5, 6, 10x. In this manuscript, we show the surgical risk (EuroSCORE) per patient group, the observed postoperative mortality and the adjusted mortality rates (real mortalityyexpected mortality). The decrease in mortality turned out to be particularly significant in the octogenarian group w7.4% (observed) against 12.14% (predicted)x. This deviation has also been noticed by other authors w11x and could be explained as a maladjusted risk score to predict postoperative mortality in particular patient subgroups like those over 80 years of age.
The postoperative results in both groups were very similar as no significant differences either in mortality (Ps0.805) or in grouped MACCEs (Ps0.719) were detected. These results coincide with those obtained in other already published series w6x. With regards to surgical details, a predilection for heterologous biological implants on behalf of Results expressed in n (%) or median winterquartile range (IQR)x. P-0.05 are considered significant. MACCEs, major adverse cardio and cerebrovascular events; ACVA, acute cerebrovascular accident; R.F. HFyHD, renal failure which required haemofiltration or haemodialysis; AMI, acute myocardial infarction. Stepwise backward binary logistic regression analysis with likelihood ratio tests. Only predicting variables are shown. CABG, coronary artery bypass grafting; MACCEs, major adverse cardio and cerebrovascular events. A significant difference in the non-adjusted survival between the two age groups can be observed during the follow-up (Ps0.002). This fact does not seem to be due to a higher cardiac mortality (Ps0.166) and could probably be explained by demises caused from age related comorbidities. These facts corroborate those already published in other series w5, 11x.
As expected, patient over 80 years had a worst survival than younger ones (HRs2.44, Ps0.025). On the other hand, when analysing cardiac mortality, octogenarians did not seem to have worse outcomes than youngers (HRs2. 26, Ps0.080) . This fact could be explained to two factors: first, the sample size may have not been large enough to detect the differences; and second, the follow-up time has not been probably long enough.
Conventional AVR has improved its outcomes in octogenarians in the past two decades. Besides, it seems that predicted morbimortality in this group of patients may be overestimated by widespread used risk stratification scales, such as EuroSCORE. Many old patients are not referred for an AVR because poor outcomes are expected according to these scores. This and other reports might show us that those are not as bad as thought and, therefore, many of those patients could safely undergo a conventional AVR and improve their functional status and lifetime expectancy.
Results of new transapical and transfemoral aortic valvular implantation techniques have been very encouraging up to date w15x. However, according to the current status of conventional AVR shown in this and other reports, we have to be cautious when choosing a trans-catheter option in detriment of a conventional surgery. Comparative studies (conventional vs. transcatheter) are necessary to ascertain in what subgroups of patients less invasive techniques are safer and more cost effective than conventional AVR. Age alone should not be used to decide on one or another treatment. Instead, a precise individual risk profile including age and comorbidities would be a wiser manner to select patients for each technique.
